You might want to take a look at Prothena Corporation plc (PRTA) now

With 1.02 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.19 shares. The 52-week range on PRTA shows that it touched its highest point at $79.65 and its lowest point at $24.28 during that stretch. It currently has a 1-year price target of $75.09. Beta for the stock currently stands at 0.23.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PRTA was up-trending over the past week, with a rise of 10.13%, but this was down by -20.88% over a month. Three-month performance dropped to -19.63% while six-month performance fell -54.50%. The stock lost -48.70% in the past year, while it has lost -21.90% so far this year. A look at the trailing 12-month EPS for PRTA yields -1.43 with Next year EPS estimates of -4.44. For the next quarter, that number is -1.18. This implies an EPS growth rate of -12.92% for this year and -59.09% for next year. EPS is expected to decline by -0.60% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 9.51%.

Float and Shares Shorts:

At present, 52.10 million PRTA shares are outstanding with a float of 50.47 million shares on hand for trading. On Jan 31, 2024, short shares totaled 5.75 million, which was 10.71% higher than short shares on Dec 29, 2023. In addition to PRTS as the firm’s, Inc., PRTA serves as its Prothena Corporation plc.

Institutional Ownership:

Through their ownership of 101.19% of PRTA’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PRTA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With PRTA analysts setting a high price target of $100.00 and a low target of $36.00, the average target price over the next 12 months is $75.09. Based on these targets, PRTA could surge 252.36% to reach the target high and rise by 26.85% to reach the target low. Reaching the average price target will result in a growth of 164.59% from current levels.

Summary of Insider Activity:

Insiders traded PRTA stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 46 while that of sell transactions has risen to 98 over the past year. The total number of shares bought during that period was 408,333 while 408,333 shares were sold.